HRT Financial’s Pliant Therapeutics PLRX Stock Holding History

HRT Financial’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14K	Sell	11,196 -21,009	-65%	-$26.5K	﹤0.01%	3606
2025 Q4	$39K	Buy	+32,205	New	+$48.4K	﹤0.01%	2908
2025 Q3	–	Sell	-32,475	Closed	-$37K	–	3478
2025 Q2	$37K	Buy	+32,475	New	+$45.9K	﹤0.01%	2343
2024 Q1	–	Sell	-28,430	Closed	-$514K	–	2909
2023 Q4	$514K	Buy	+28,430	New	+$432K	﹤0.01%	1347
2023 Q2	–	Sell	-165,512	Closed	-$4.4M	–	3085
2023 Q1	$4.4M	Buy	+165,512	New	+$4.71M	0.05%	284
2022 Q4	–	Sell	-11,339	Closed	-$236K	–	2984
2022 Q3	$236K	Buy	+11,339	New	+$217K	﹤0.01%	2144
2022 Q1	–	Sell	-39,298	Closed	-$530K	–	3686
2021 Q4	$530K	Buy	+39,298	New	+$625K	﹤0.01%	1707

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

HRT Financial's PLRX Position: Q1 2026 in Review

HRT Financial reduced its Pliant Therapeutics (PLRX) stake by 65% in Q1 2026, selling an estimated $26.5K and leaving 11,196 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

HRT Financial first reported a position in PLRX in Q4 2021 and has held it in 7 quarters since. The position peaked at $4.4M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

HRT Financial held 11,196 shares of Pliant Therapeutics worth $14K as of Q1 2026.
HRT Financial sold 21,009 Pliant Therapeutics shares in Q1 2026, an estimated $26.5K.
Pliant Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3606 holding.
HRT Financial first reported a position in Pliant Therapeutics in Q4 2021 and has held it in 7 quarters since.
HRT Financial's Pliant Therapeutics position peaked at $4.4M in Q1 2023.
91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.